Clinical Trials in Michigan

Showing 8581-8600 of 12,290 trials

Mothers in Motion Program to Prevent Weight Gain in WIC Mothers (MIM)

NCT01839708

Mothers in Motion will draw on the successes of the pilot intervention of the same name and will promote healthy lifestyle behavior changes (eating more fruits and vegetables, increasing physical activity, dealing with stress) in low-income WIC mothers of young children. The intervention group's weight change (difference between the initial enrollment and 3 months post intervention) will differ from the control group's weight change by an average of at least 2.8 pounds.

OverweightObesity

Ohio State University569 participantsStarted Sep 2011

East Lansing, Michigan, United States • Columbus, Ohio, United States

COMPLETEDPhase 241 miles

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

NCT00666588

This phase II trial is studying the side effects and best dose of bortezomib and to see how well it works when given together with combination chemotherapy in treating younger patients with recurrent, refractory, or secondary acute myeloid leukemia (AML). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as idarubicin, cytarabine, and etoposide, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) together with bortezomib may kill more cancer cells

Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)Adult Acute Myeloblastic Leukemia With Maturation (M2)+19 more

National Cancer Institute (NCI)52 participantsStarted Apr 2008

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +79 more locations

Mothers in Motion Program to Prevent Weight Gain in WIC Mothers (MIM)

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

Find Trials by Condition in Michigan

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

PF-00489791 For The Treatment Of Raynaud's

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Phase 1 and 2 Study of PX-866 and Cetuximab

Bilateral Cochlear Implantation in Children With the MED-EL Cochlear Implant

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Thrombolysis in Pediatric Stroke (TIPS)

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia.

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)

A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures